Modeling the use of innovations in private treatment organizations: the role of absorptive capacity

scientific article

Modeling the use of innovations in private treatment organizations: the role of absorptive capacity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0740-5472(03)00158-2
P698PubMed publication ID14698799

P2093author name stringHannah K Knudsen
Paul M Roman
P2860cites workThe Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational FieldsQ24256434
Innovations in treatment for drug abuse: solutions to a public health problemQ34198644
Illegal drug use among rural adults: mental health consequences and treatment utilizationQ39451223
Treatment of cocaine and alcohol dependence with psychotherapy and disulfiramQ39472627
The value of acupuncture detoxification programs in a substance abuse treatment system.Q39524037
One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatmentQ39550515
Rural and urban similarities and differences in private substance abuse treatment centersQ39677211
Mission unfulfilled: potholes on the road to mental health parityQ40796714
Manualized treatment for substance abusers with personality disorders: dual focus schema therapyQ43070618
Technology transfer through performance management: the effects of graphical feedback and positive reinforcement on drug treatment counselors' behavior.Q43620003
Acupuncture for the treatment of cocaine addiction: a randomized controlled trialQ43832029
Adoption and implementation of new technologies in substance abuse treatment.Q44033265
Substance user treatment program quality: selected topicsQ44103409
Staff beliefs about addiction treatmentQ47612604
Muddling through elegantly: finding the proper balance in rationingQ47779447
A national study of the substance abuse treatment workforceQ48025234
Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusersQ48611230
Substance abuse treatment staff: recovery status and approaches to treatment.Q50875227
Organizational process: a missing link between research and practice.Q51961802
Manual-guided cognitive-behavioral therapy training: a promising method for disseminating empirically supported substance abuse treatments to the practice community.Q51965851
A latent variable model of evidence-based quality improvement for substance abuse treatment.Q51967066
Recovering substance abuse staff members' beliefs about addiction.Q52274007
A social marketing model for disseminating research-based treatments to addictions treatment providers.Q52276663
The federal role in drug abuse technology transfer: a history and perspective.Q53430425
Absorptive Capacity: A New Perspective on Learning and InnovationQ56170044
Organizational Complexity and Innovation: Developing and Testing Multiple Contingency ModelsQ56456934
Predicting closure of private substance abuse treatment facilitiesQ57218896
Counselors in Public and Private Alcoholism and Drug Abuse Treatment ProgramsQ58294912
Program Change and Organizational Properties a Comparative AnalysisQ72346103
A conceptual framework for transferring research to practiceQ74318938
Transporting a research-based adolescent drug treatment into practiceQ74318946
A discussion of the concept of technology transfer of research-based drug "abuse" prevention and treatment interventionsQ74614674
Organizational and professional characteristics predicting external communications in Canadian public health unitsQ77151405
Play therapy and art therapy for substance abuse clients who have a history of incest victimizationQ77815416
The Adoption of Radical and Incremental Innovations: An Empirical AnalysisQ99301486
ORGANIZATIONAL INNOVATION: A META-ANALYSIS OF EFFECTS OF DETERMINANTS AND MODERATORSQ99301494
P433issue1
P304page(s)353-361
P577publication date2004-01-01
P1433published inJournal of Substance Abuse TreatmentQ15762042
P1476titleModeling the use of innovations in private treatment organizations: the role of absorptive capacity
P478volume26

Reverse relations

cites work (P2860)
Q36541145A Rasch model analysis of evidence-based treatment practices used in the criminal justice system
Q37193168A categorical typology of naltrexone-adopting private substance abuse treatment centers
Q37642887A comparison of how behavioral health organizations utilize training to prepare for health care reform
Q36539484A national survey of substance abuse treatment for juvenile offenders
Q36321023A structural model of treatment program and individual counselor leadership in innovation transfer
Q35203808A systematic review of the psychometric properties of self-report research utilization measures used in healthcare
Q90210449Acquisition of Information About Innovative Practices in Outpatient Mental Health Clinics
Q35923250Adaptability of contingency management in justice settings: survey findings on attitudes toward using rewards
Q37406433Adaptation of an evidence-based intervention targeting HIV-infected prisoners transitioning to the community: the process and outcome of formative research for the Positive Living Using Safety (PLUS) intervention
Q52298463Addiction treatment provider attitudes on staff capacity and evidence-based clinical training: results from a national study.
Q37216771Adolescent-only substance abuse treatment: availability and adoption of components of quality
Q37580421Adoption and diffusion of evidence-based addiction medications in substance abuse treatment
Q34607338Adoption and implementation of medications in addiction treatment programs
Q34543143Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S
Q35129867An exploratory study of alternative configurations of governing boards of substance abuse treatment centers
Q37067963Associations among state and local organizational contexts: Use of evidence-based practices in the criminal justice system
Q35621950Availability and capacity of substance abuse programs in correctional settings: A classification and regression tree analysis
Q51920239Availability of integrated care for co-occurring substance abuse and psychiatric conditions.
Q36944935Community opioid treatment perspectives on contingency management: perceived feasibility, effectiveness, and transportability of social and financial incentives
Q33966758Competing values among criminal justice administrators: The importance of substance abuse treatment
Q30374904Counselor Attitudes Toward Contingency Management for Substance Use Disorder: Effectiveness, Acceptability, and Endorsement of Incentives for Treatment Attendance and Abstinence.
Q34222652Counselor Attitudes toward the Use of Motivational Incentives in Addiction Treatment
Q28396690Counselor perceptions of organizational factors and innovations training experiences
Q34076189Diffusion of Contingency Management and Attitudes regarding Its Effectiveness and Acceptability
Q51928186Does service diversification enhance organizational survival?: Evidence from the private substance abuse treatment system.
Q33810987Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector
Q36640365Empirically supported substance abuse treatment approaches: a survey of treatment providers' perspectives and practices
Q38754870End-of-Life Care Planning in Accountable Care Organizations: Associations with Organizational Characteristics and Capabilities
Q33617847Evidence-based practice implementation: the impact of public versus private sector organization type on organizational support, provider attitudes, and adoption of evidence-based practice
Q24633657Evidence-based practices in addiction treatment: review and recommendations for public policy
Q35827981Evidence-based treatment practices for drug-involved adults in the criminal justice system
Q34111054Facilitating Factors and Barriers to the Use of Medications in Publicly Funded Addiction Treatment Organizations
Q47957049Factors associated with an evidence-based measure of implementation for the Adolescent Community Reinforcement Approach.
Q35865698HIV testing in correctional agencies and community treatment programs: the impact of internal organizational structure
Q36972481Identifying and ranking implicit leadership strategies to promote evidence-based practice implementation in addiction health services
Q36461870Implementation of Electronic Health Records and Entrepreneurial Strategic Orientation in Substance Use Disorder Treatment Organizations.
Q35713149Innovation adoption as facilitated by a change-oriented workplace
Q36627877Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.
Q35021468Insights from a national survey into why substance abuse treatment units add prevention and outreach services
Q36322546Longitudinal Examination of Medical Staff Utilization in Substance Use Disorder Treatment Organizations
Q34258997Managerial capacity and adoption of culturally competent practices in outpatient substance abuse treatment organizations
Q34362703Measures for Predictors of Innovation Adoption
Q38988573Organizational Factors and Probation Officer Use of Evidence-Based Practices
Q46743330Organizational change in a perinatal treatment setting: integration of clinical practice and policies on tobacco and smoking cessation
Q35928356Organizational characteristics of drug abuse treatment programs for offenders.
Q35222515Organizational characteristics that foster early adoption of cultural and linguistic competence in outpatient substance abuse treatment in the United States
Q44779101Organizational determinants of boundary spanning activity in outpatient substance abuse treatment programmes
Q34384706Organizational factors associated with the use of contingency management in publicly funded substance abuse treatment centers
Q51917831Perceived impact by administrators of psychiatric emergency services after changes in a state's mental health system.
Q87158058Predictors of the decision to adopt motivational interviewing in community health settings
Q46198248Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs
Q37224883Research on the diffusion of evidence-based treatments within substance abuse treatment: a systematic review
Q36643013Rural substance use treatment centers in the United States: an assessment of treatment quality by location
Q51905425Service delivery in substance abuse treatment: reexamining "comprehensive" care.
Q36766544State policy influence on the early diffusion of buprenorphine in community treatment programs
Q35736844Systems antecedents for dissemination and implementation: a review and analysis of measures
Q36118446Taking Effective Treatments to Scale: Organizational Effects on Outcomes of Multisystemic Therapy for Youth with Co-occurring Substance Use.
Q34766519Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users
Q33622979The Place of Adoption in the NIDA Clinical Trials Network
Q33716545The adoption of alcohol pharmacotherapies in the Clinical Trials Network: the influence of research network participation
Q35792939The adoption of medications in substance abuse treatment: associations with organizational characteristics and technology clusters
Q40201753The use of antidepressant medications in substance abuse treatment: the public-private distinction, organizational compatibility, and the environment
Q37648682Therapist predictors of treatment delivery fidelity in a community-based trial of 12-step facilitation.
Q35577449Timing of buprenorphine adoption by privately funded substance abuse treatment programs: the role of institutional and resource-based interorganizational linkages
Q34292827Total quality management and performance in substance abuse treatment centers
Q35875486Treatment strategy profiles in substance use disorder treatment programs: A latent class analysis
Q34037035What Influences Participation in QI? A Randomized Trial of Addiction Treatment Organizations
Q36209934Workforce diversity in outpatient substance abuse treatment: the role of leaders' characteristics
Q35508804Workforce professionalism in drug treatment services: impact of California's Proposition 36

Search more.